“The influence of sodium-glucose co-transporter-2 inhibitors on the risk of cancer therapy-related cardiac dysfunction: A meta-analysis” (2025) Biomolecules and Biomedicine, 25(8), pp. 1723–1736. doi:10.17305/bb.2025.11847.